Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies
- Bioorg Med Chem Lett. 2009 Sep 1;19(17):5063-6. doi: 10.1016/j.bmcl.2009.07.040.
Affiliations
- 1. Bristol-Myers Squibb Pharmaceutical Research and Development, Princeton, NJ 08543, USA. [email protected]
PMID: 19632837
DOI: 10.1016/j.bmcl.2009.07.040
Abstract
Hit to Lead optimization and SAR development led to the identification of the potent and selective benzo[d]imidazole inhibitor (17b) of Co-activator Associated Arginine Methyltransferase (CARM1).
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Histone MethyltransferaseResearch Areas: Cancer
-
target: Histone MethyltransferaseResearch Areas: Cancer